L3VLUP
ProSign in

MMSI · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MMSIJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MMSI
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterMMSIJNJ
Q3 20202 holders, $196m30 holders, $26.2bn
Q4 20202 holders, $222m32 holders, $26.6bn
Q1 20213 holders, $238m31 holders, $25.3bn
Q2 20214 holders, $255m37 holders, $25.6bn
Q3 20214 holders, $259m40 holders, $24.1bn
Q4 20214 holders, $98m33 holders, $25.2bn
Q1 20223 holders, $75m35 holders, $28.2bn
Q2 20224 holders, $48m33 holders, $26.9bn
Q3 20223 holders, $19m36 holders, $25.4bn
Q4 20223 holders, $19m35 holders, $27.6bn
Q1 20232 holders, $19m42 holders, $24.5bn
Q2 20232 holders, $6.8m38 holders, $25.0bn
Q3 20232 holders, $17m37 holders, $18.9bn
Q4 20233 holders, $26m31 holders, $19.0bn
Q1 20244 holders, $38m32 holders, $19.7bn
Q2 20246 holders, $138m35 holders, $20.4bn
Q3 20247 holders, $148m28 holders, $22.3bn
Q4 20245 holders, $75m37 holders, $20.4bn
Q1 20255 holders, $250m32 holders, $20.5bn
Q2 20255 holders, $271m31 holders, $18.4bn
Q3 20255 holders, $210m32 holders, $23.7bn
Q4 20257 holders, $171m29 holders, $27.8bn
Q1 20268 holders, $192m34 holders, $35.6bn
Q2 20266 holders, $169m33 holders, $39.1bn
MMSI

Merit Med Sys Inc

Holders
7
Reported value
$148m
Buyers
4
Sellers
2

Breadth +2 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
28
Reported value
$22.3bn
Buyers
13
Sellers
16

Breadth -3 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2024

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MMSI (5)

Farallon Capital Management LLC, Point72 Asset Management LP, Quantbot Technologies LP, Tudor Investment Corp, Two Sigma Investments LP

Only JNJ (26)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Walleye Capital LLC, Wellington Management Group LLP, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →